rabeprazole sodium (Sartorius AG)
Structured Review
Rabeprazole Sodium, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabeprazole+sodium/Entris+II+Essential+Line+Analytical+Balance+220+gr/pm38897632-23-12-20
Average 93 stars, based on 14 article reviews
Images
Related Articles
Formulation:Article Title: 13-Week Repeated Oral Toxicity and Toxicokinetic Studies of Rabeprazole Sodium and Sodium Bicarbonate Combination in Dogs. Article Snippet: The subchronic toxicity and toxicokinetics of a combination of rabeprazole sodium and sodium bicarbonate were investigated in dogs by daily oral administration for 13 consecutive weeks with a 4-week recovery period.. The dose groups consisted of control (vehicles), (5 + 200), (10 + 400), and (20 + 800) mg/kg of rabeprazole sodium + sodium bicarbonate, 20 mg/kg of rabeprazole sodium only, and 800 mg/kg of sodium bicarbonate only.. Esophageal ulceration accompanied by inflammation was observed in only one animal in the male (20 + 800) mg/kg rabeprazole sodium + sodium bicarbonate group. Capsules:Article Title: 13-Week Repeated Oral Toxicity and Toxicokinetic Studies of Rabeprazole Sodium and Sodium Bicarbonate Combination in Dogs. Article Snippet: The subchronic toxicity and toxicokinetics of a combination of rabeprazole sodium and sodium bicarbonate were investigated in dogs by daily oral administration for 13 consecutive weeks with a 4-week recovery period.. The dose groups consisted of control (vehicles), (5 + 200), (10 + 400), and (20 + 800) mg/kg of rabeprazole sodium + sodium bicarbonate, 20 mg/kg of rabeprazole sodium only, and 800 mg/kg of sodium bicarbonate only.. Esophageal ulceration accompanied by inflammation was observed in only one animal in the male (20 + 800) mg/kg rabeprazole sodium + sodium bicarbonate group. |
![<t>Rabeprazole</t> sodium inhibited CeENGASE in vitro and improved wild-type worms stress adaptivity in vivo. a CeENGASE expressed in E. coli BL21 (DE3) was purified and subjected to an in vitro assay to release N-glycans on RNaseB. The products of the assay were analyzed by MALDI-TOF MS, and N2H3F1X1 (1221) was used as an internal control. The ratio of the main product (N1H7, 1378) to the internal reference (N2H3F1X1, 1211) decreased by about 50 times, indicating that Rabeprazole sodium inhibited the enzymatic activity of CeENGASE. b The survival rate of wild-type worms (on plate supplied with 150 μL of Rabeprazole sodium [1 m m ]) after 7-h heat treatment. The survival rate of Rabeprazole sodium group was 26.48% more than the control group (control vs. Rabeprazole sodium: 10.12% vs. 36.60%).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7103/pmc12187103/pmc12187103__cto-2025-0000-0000-546244_F06.jpg)
![<t>Rabeprazole</t> sodium inhibited CeENGASE in vitro and improved wild-type worms stress adaptivity in vivo. a CeENGASE expressed in E. coli BL21 (DE3) was purified and subjected to an in vitro assay to release N-glycans on RNaseB. The products of the assay were analyzed by MALDI-TOF MS, and N2H3F1X1 (1221) was used as an internal control. The ratio of the main product (N1H7, 1378) to the internal reference (N2H3F1X1, 1211) decreased by about 50 times, indicating that Rabeprazole sodium inhibited the enzymatic activity of CeENGASE. b The survival rate of wild-type worms (on plate supplied with 150 μL of Rabeprazole sodium [1 m m ]) after 7-h heat treatment. The survival rate of Rabeprazole sodium group was 26.48% more than the control group (control vs. Rabeprazole sodium: 10.12% vs. 36.60%).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7103/pmc12187103/pmc12187103__cto-2025-0000-0000-546244_F06.jpg.jpg)

